T Cell Cytotoxicity to Epstein-Barr Virus Infected B Cells: Comparison of Patients with Rheumatoid Arthritis and Their HLA Identical Siblings

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 1988 Apr 1

PMID 2835019

Citations 2

Authors

V R Winrow

J Norton

E J HOLBOROW

H E Stierle

A Young

J A Sachs

Affiliations

Soon will be listed here.

Abstract

Specific T cell cytotoxicity to Epstein-Barr virus (EBV) infected B cells is reported to be abnormal in rheumatoid arthritis (RA). The regression phenomenon was used to determine whether the immunoregulatory defect in RA is restricted to T cells, B cells, or HLA type. Peripheral blood T and B cells from patients with RA and their HLA identical healthy siblings were mixed in varying ratios with and without EBV, and thymidine incorporation was measured on days 7, 14, and 21. The results suggest that the T cell abnormality is related to disease activity and that an inherent defect exists in the rheumatoid B cell which is independent of disease activity.

Citing Articles

Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma.

Lee Y, Hwang Y, Chen K, Lin Y, Huang D, Huang T Funct Integr Genomics. 2006; 7(1):79-93.

PMID: 16988809 DOI: 10.1007/s10142-006-0035-2.

The Epstein-Barr virus in autoimmunity.

Vaughan J Springer Semin Immunopathol. 1995; 17(2-3):203-30.

PMID: 8571169 DOI: 10.1007/BF00196166.

References

Thorley-Lawson D, Chess L, Strominger J . Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes. J Exp Med. 1977; 146(2):495-508. PMC: 2180764. DOI: 10.1084/jem.146.2.495. View

Moss D, Rickinson A, Pope J . Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer. 1978; 22(6):662-8. DOI: 10.1002/ijc.2910220604. View

Slaughter L, Carson D, JENSEN F, Holbrook T, Vaughan J . In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med. 1978; 148(5):1429-34. PMC: 2185048. DOI: 10.1084/jem.148.5.1429. View

Young A, Corbett M, Brook A . The clinical assessment of joint inflammatory activity in rheumatoid arthritis related to radiological progression. Rheumatol Rehabil. 1980; 19(1):14-9. DOI: 10.1093/rheumatology/19.1.14. View

Bardwick P, Bluestein H, Zvaifler N, Depper J, Seegmiller J . Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum. 1980; 23(6):626-32. DOI: 10.1002/art.1780230603. View

Kaplan M, Clark C . An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods. 1974; 5(2):131-5. DOI: 10.1016/0022-1759(74)90003-9. View

Hasler F, Bluestein H, Zvaifler N, Epstein L . Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation. J Exp Med. 1983; 157(1):173-88. PMC: 2186886. DOI: 10.1084/jem.157.1.173. View

Gaston J, Rickinson A, Epstein M . Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients. Rheumatol Int. 1982; 2(4):155-9. DOI: 10.1007/BF00286137. View

Konttinen Y, Bluestein H, Zvaifler N . Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells. J Immunol. 1985; 134(4):2287-93. View

10.

Ohta Y, Fujiwara K, Nishi T, Oka H . Normal values of peripheral lymphocyte populations and T cell subsets at a fixed time of day: a flow cytometric analysis with monoclonal antibodies in 210 healthy adults. Clin Exp Immunol. 1986; 64(1):146-9. PMC: 1542156. View

11.

Gaston J, Rickinson A, Yao Q, Epstein M . The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies. Ann Rheum Dis. 1986; 45(11):932-6. PMC: 1002022. DOI: 10.1136/ard.45.11.932. View

12.

Tosato G, Steinberg A, Blaese R . Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med. 1981; 305(21):1238-43. DOI: 10.1056/NEJM198111193052102. View